Free Annual ReportsPfizer Inc $ 29.04
+0.40
Digital Company Profile
| Last Trade: | 29.04 |
| Trade Time: | Sep 18 06:40 PM Eastern Daylight Time |
| Change: | 0.40 (1.40 %) |
| Prev Close: | 28.64 |
| Open: | 28.73 |
| Bid: | 29.05 |
| Ask: | 29.07 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
Get PFE Trend Analysis
-
it has outperformed the S&P 500 by 3%
ETF Alternatives
| Ticker | Name | Weight | % Change |
|---|---|---|---|
| XLV | Health Care Select Sector SPDR | 9.99% | +0.62% |
| IYH | iShares U.S. Healthcare ETF | 9.26% | +0.67% |
| PPH | Market Vectors Pharmaceutical ETF | 9.01% | +1.02% |
| IHE | iShares U.S. Pharmaceuticals ETF | 8.82% | +0.56% |
| VHT | Vanguard Health Care ETF | 8.32% | +0.59% |
| RXL | ProShares Ultra Health Care | 7.04% | +1.28% |
| IXJ | iShares S&P Global Healthcare | 6.16% | +1.21% |
| HDV | iShares High Dividend ETF | 5.66% | +1.33% |
| PJP | PowerShares Dynamic Pharmaceuticals | 4.82% | +0.70% |
Competitors
| Ticker | Name | Volume | % Change |
|---|---|---|---|
| MRK | Merck & Co Inc | 14.01M | +0.81% |
| BMY | Bristol Myers Squibb Co | 10.39M | +2.47% |
| JNJ | Johnson & Johnson | 10.09M | +0.95% |
| ELTP | Elite Pharmaceuticals Inc | 9.90M | +21.50% |
| DNDN | Dendreon Corp | 7.33M | +3.51% |
Insider Transactions
| Date | Name | Title | Volume | Trade Price | Holding Change |
|---|---|---|---|---|---|
| 8/12/2013 | CORNWELL W DON | Director | 758 | $29.09 | 51.95% |
| 8/12/2013 | CORNWELL W DON | Director | -758 | $29.09 | -34.19% |
| 7/31/2013 | CANGIALOSI LORETTA V | Sr. Vice President, Controller | -6,688 | $29.71 | -3.37% |
| 7/31/2013 | CANGIALOSI LORETTA V | Sr. Vice President, Controller | -8,000 | $29.56 | -4.17% |
| 7/31/2013 | HILL CHARLES H | Executive Vice President | -56,871 | $29.64 | -43.17% |
Data provided by Insiderslab.com.
To read detailed Insider Trading Research Report for (
PFE ), click here.
PFE Stock Analysis
-
Q2 Earnings Season Winding Down - Earnings Trends
-
Better Margins Can't Hide Merck's Growth Challenges
-
Tentative Markets Ahead of Big Data - Ahead of Wall Street
-
Pharma & Biotech Stock Outlook - July/Aug 2013 - Industry Outlook
-
Pharma & Biotech Stock Outlook - July/Aug 2013 - Industry Outlook
-
Wall Street Happy To Hum La AbbVie En Rose
-
Free Managed Futures Book
Get the four benefits of managed futures as outlined in this booklet. -
View the Portfolios of the Worlds Top Investors, FREE!
Learn from Warren Buffett, George Soros and More! -
7 Proven Strategies for Market-Stomping Stocks
Discover Investing Strategies that will Benefit Every Investor Today!
Free Annual Reports